RankAlpha logo
Back to Rankings

CGEN

CompugenA
Nasdaq / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
Quote time unavailable
View Chart

Operating peers and competitors

Source-backed product markets and frozen research comparisons. Valuation comparators remain in the existing peer table.

Loading market evidence...

Research comparisons do not establish forecast usefulness or trading returns.

Compare shared product markets

Membership only; no portfolio weights or estimated losses.

+
Peers tracked
9
U.S. public peers
Grade Position
Above peers
vs peer average
CGEN vs peer average
91/100
CGEN vs. peer average (A vs. D)
Grade spread
B 2 · C 1 · D 5 · F 1
Graded peers loaded
Coverage
9 graded
100% of tracked

Peer overview

DTIL is the first available peer comparator.

Packet-selected small-cap biotechnology comparison by market capitalization only; no verified shared indication or trial design, so it is not a direct COM701 valuation anchor.

✓Peer source comes from the stored AI memo or peer model
✓Grades and factor rows use RankAlpha API data when available
✓Missing peer scores remain blank instead of being estimated
✓Side-by-side comparison keeps the data contract visible
Top peerDTILPrecision BioSciences
CGEN
Compugen
DTIL
Precision BioSciences
Grade
A
D
Momentum
89
72
Value
56
41
Sentiment
71
40
Setup Bias
Net —
-
Market Cap
-
-
Posture
Constructive
Defensive

Grade position vs DTIL

CGEN / DTIL
Grade Position
Above peers
CGEN vs. peer average (A vs. D)
91/100
Momentum
89
CGEN
Value
56
CGEN
Sentiment
71
CGEN

Rotation landscape

Peers ranked by the order returned from the peer source, with grades from the API.

Rank
Ticker
Company
Grade
Grade score
vs CGEN
1
DTIL
DTIL
D
40/100
-3
2
ZNTL
ZNTL
B
80/100
-1
3
PRQR
ProQR Therapeutics NV Common
F
20/100
-4
4
RNAC
Cartesian Therapeutics Inc Common
D
40/100
-3
5
RNA
Atrium Therapeutics Inc Common
C
60/100
-2
DTIL is the first peer returned for this comparison set.